- Home
- ULH vs RLAY Comparison
ULH vs RLAY Comparison
Compare ULH & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULH
- RLAY
- Stock Information
- Founded
- ULH 1932
- RLAY 2015
- Country
- ULH United States
- RLAY United States
- Employees
- ULH N/A
- RLAY N/A
- Industry
- ULH Trucking Freight/Courier Services
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ULH Industrials
- RLAY Health Care
- Exchange
- ULH Nasdaq
- RLAY Nasdaq
- Market Cap
- ULH 701.1M
- RLAY 620.4M
- IPO Year
- ULH 2005
- RLAY 2020
- Fundamental
- Price
- ULH $26.24
- RLAY $2.62
- Analyst Decision
- ULH Hold
- RLAY Strong Buy
- Analyst Count
- ULH 1
- RLAY 10
- Target Price
- ULH $44.00
- RLAY $19.33
- AVG Volume (30 Days)
- ULH 53.3K
- RLAY 2.5M
- Earning Date
- ULH 04-24-2025
- RLAY 05-01-2025
- Dividend Yield
- ULH 1.58%
- RLAY N/A
- EPS Growth
- ULH 39.66
- RLAY N/A
- EPS
- ULH 4.93
- RLAY N/A
- Revenue
- ULH $1,846,035,000.00
- RLAY $10,007,000.00
- Revenue This Year
- ULH N/A
- RLAY N/A
- Revenue Next Year
- ULH $7.92
- RLAY $544.28
- P/E Ratio
- ULH $5.40
- RLAY N/A
- Revenue Growth
- ULH 11.06
- RLAY N/A
- 52 Week Low
- ULH $25.13
- RLAY $2.45
- 52 Week High
- ULH $53.29
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- ULH 38.22
- RLAY 32.07
- Support Level
- ULH $26.02
- RLAY $3.05
- Resistance Level
- ULH $27.91
- RLAY $3.08
- Average True Range (ATR)
- ULH 1.03
- RLAY 0.25
- MACD
- ULH 0.49
- RLAY -0.04
- Stochastic Oscillator
- ULH 33.20
- RLAY 11.64
About ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).